Recursion Pharmaceuticals, Inc. RXRX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Recursion Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Recursion Pharmaceuticals, Inc. (RXRX) reported common stock, shares issued (in shares) of $530.63M in Q1 2026.
- How has Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares) increased by 30.6% year-over-year, from $406.41M to $530.63M.
- What is the long-term trend for Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s common stock, shares issued (in shares) has grown at a 88.3% compound annual growth rate (CAGR), from $22.31M to $528.18M.